|
|
 Specialty Pharma 
How do you want to know us? As a company who is making strides in reaching a range of oncology cures to CIS countries? A company that is known in the industry as having a firm grasp of modern delivery technologies? As an ideal outsourcing partner in geographies of choice? Or simply as a discovery company in the areas of arthritis and more? Starting in 90s, the Pharma Division of Vivimed Labs is today seen as a preferred partner by large global players in the areas of collaborative research, joint exploration of new markets and as an efficient supply chain partner who can leverage globally benchmarked plants. The Specialty Pharma Division is an impactful combination of all the qualities of a big and small pharmaceutical company. Our size gives us the agility to build beneficial relationships with the medical community and flexible collaborative partnerships with other pharmaceutical companies. We have fully integrated resources in R&D, regulatory affairs and manufacturing, coupled with a comprehensive and fully aligned sales force. All these blended with a 'can do' attitude enable us to move quickly and capitalize on scientific advances, help in bringing innovative pharmaceuticals and technologies to market. These strategic competencies, combined with leadership, discipline and financial strength, have ensured Specialty Pharma Division as the fastest emerging, proven partner of choice. The Specialty Pharma division of Vivimed Labs is a merged entity of VVS Pharma and Creative Healthcare. The Specialty Pharma Division has its inherent strengths in drug delivery ad drug discovery. The division is focused on providing cures in the Oncology space, Arthritis, Syndrome X, Macular degeneration, Psoriasis and Stress. |
